| Code | 2277D | ||||||||||
| MA number | 64/0253/19-S | ||||||||||
| Product Form: | int opo 3x2,5 ml (fľ.LDPE) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 64 - OPHTHALMOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | bottle LDPE | ||||||||||
| Route of admin.: | Ocular use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 11.09.2019 |
| Validity: | 11.09.2024 |
| MA renewed: | Renewal application submitted |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Latanoprost Olikla int opo_04.2023.pdf
|
| SPC: |
SPC_Latanoprost Olikla_int opo_04.2023.pdf
|
| Safety feature | Yes |
| Data update: | 05.06.2023 |
